<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7140696\results\search\tropicalVirus\results.xml">
  <result pre="for certain pathogens. 2.4. ERAPs and Human Papilloma Virus (HPV)" exact="Human papilloma virus" post="(HPV) is a DNA virus and the causative agent"/>
  <result pre="a DNA virus and the causative agent of cervical cancer." exact="HPV" post="is the most common sexually transmitted infection and indeed"/>
  <result pre="population undergoes this infection sooner or later during life [74]." exact="HPV" post="infection is asymptomatic and spontaneously resolves within a couple"/>
  <result pre="in anus, vulva, vagina, penis, and oropharynx cancers [74]. Actually," exact="HPV" post="is responsible for more than 12% of cancers in"/>
  <result pre="as prevention methods: they all are thoroughly effective in preventing" exact="HPV" post="infection, especially toward types 16 and 18 viruses, responsible"/>
  <result pre="for more than half of cervical cancer cases worldwide [75]." exact="HPV" post="targets epithelial cells of the basal layer in injured"/>
  <result pre="targets epithelial cells of the basal layer in injured regions." exact="HPV" post="infection and growth are absolutely dependent upon the expression"/>
  <result pre="of the epithelium. As these cells can no longer replicate," exact="HPV" post="synthetizes the E6 and E7oncogenes—two viral proteins engaged on"/>
  <result pre="these variants in Javanese and Balinese Indonesian populations, in whom" exact="HPV" post="is almost endemic [87]. Results showed that, as in"/>
  <result pre="[88,89]. Indeed, these two Indonesian areas show a different oncogenic" exact="HPV" post="subtypes distribution suggesting that distinct HPV subtypes may evade"/>
  <result pre="show a different oncogenic HPV subtypes distribution suggesting that distinct" exact="HPV" post="subtypes may evade the immune system by hijacking different"/>
  <result pre="itself [94,95]. The most recent study seeking possible correlations between" exact="HPV" post="infection and ERAP1 has been conducted in 2019 by"/>
  <result pre="carcinoma (OPSCC)—the specificity of tumor-infiltrating CD8+ T lymphocytes (CD8+TILs) for" exact="HPV" post="epitopes has been demonstrated. In particular, analyses showed that"/>
  <result pre="Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated ImmunoevasionCell Rep.20172084685310.1016/j.celrep.2017.06.08428746870 74.DunneE.F.UngerE.R.SternbergM.McQuillanG.SwanD.C.PatelS.S.MarkowitzL.E.Prevalence of" exact="HPV" post="infection among females in the United StatesJAMA200729781381910.1001/jama.297.8.81317327523 75.ChabedaA.YanezR.J.R.LamprechtR.MeyersA.E.RybickiE.P.HitzerothI.I.Therapeutic vaccines"/>
  <result pre="11 K528R HCV, HIV rs27044 Exon 15 Q730E HCV, HIV," exact="HPV" post="rs10050860 Exon 12 D575N HPV rs26618 Exon 5 M276I"/>
  <result pre="Exon 15 Q730E HCV, HIV, HPV rs10050860 Exon 12 D575N" exact="HPV" post="rs26618 Exon 5 M276I HCV rs26653 Exon 2 P127R"/>
  <result pre="rs26618 Exon 5 M276I HCV rs26653 Exon 2 P127R HCV," exact="HPV" post="rs17481856 Exon 17 L848L Toxoplasmosis rs17481334 3’ UTR None"/>
 </snippets>
</snippetsTree>
